Latest Breaking News On - Successfully engrafted - Page 1 : comparemela.com

First Patient Dosed and Successfully Engrafted in BEACON Phase 1/2 Trial of BEAM-101 in Patients with Severe Sickle Cell Disease; Significant Enrollment Progress Supports First Expected Clinical Data.

United kingdomJohn evansDan budwickHolly manningSustainable research portfolioStrategic communicationsBeam therapeutics incExchange commissionFirst patient dosedSuccessfully engraftedSevere sickle cell diseaseSecond halfClinical trial applicationTrial initiationDeficiency plannedFirst half